NIDDK
-
A step toward gastric cancer
New research findings provide insight into the detrimental events that develop in response to H. pylori infection. Read MoreOctober 3, 2019
-
Treating C. diff: new purpose for an old drug?
An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice. Read MoreSeptember 24, 2019
-
Microvilli in motion
Live cell imaging studies have revealed that microvilli — finger-like protrusions on the surface of epithelial cells — move and collide as they form the brush border. Read MoreSeptember 19, 2019
-
Host-microbe interactions in the gut
Vanderbilt investigators demonstrated that intestinal cells promote beneficial microbe behavior — the findings support developing microbiota-based therapies for intestinal health. Read MoreAugust 13, 2019
-
Pancreatic cancer clue
Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer. Read MoreAugust 12, 2019
-
A probiotic treatment for obesity?
Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases. Read MoreAugust 8, 2019
-
Intestinal immune cell interactions
Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases. Read MoreJuly 30, 2019
-
New role for microtubules in diabetes
Microtubules, part of the cell's cytoskeleton, regulate the secretion of insulin, suggesting that they may be a new target for treating diabetes. Read MoreJuly 29, 2019
-
Sex differences in kidney injury
Men are more susceptible to progressive kidney disease than women; new VUMC studies point to differences in the expression and activation of the EGF receptor. Read MoreJuly 25, 2019
-
New look at atherosclerosis
A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques. Read MoreJuly 11, 2019